Radiopharmeaceuticals

Radiopharmaceuticals are drugs that contain radioactive materials, known as radioisotopes. These drugs may be administered by multiple routes and travel to the body to treat cancer or to reduce symptoms. Radiopharmaceuticals release radiation (alpha and beta particles) that target the affected areas.
 
Everyone responds to radiopharmaceuticals differently. Talk to your doctor or pharmacist about what to expect, including any side-effects you may experience while on these medications. Some therapies used to treat prostate cancer may interact with other prescription or non-prescription medications you are taking. Tell your doctor or pharmacist if you are taking any medications.
 
Below is a list of common radiopharmaceuticals used to treat prostate cancer. Click on each drug name for further information including:
 
  • what the drug is and how it works
  • how the drug is administered
  • possible side effects of the drug
  • whether the drug is covered by your provincial drug program

Radium 223 Dichloride (Xofigo)
 




 

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive